The antibiotic drug tigecycline: A focus on its promising anticancer properties

Tigecycline (TIG), the first member of glycylcycline bacteriostatic agents, has been approved to treat complicated infections in the clinic because of its expanded-spectrum antibiotic potential. Recently, an increasing number of studies have emphasized the anti-tumor effects of TIG. The inhibitory e...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Zhijie Xu, Yuanliang Yan, Zhi Li, Long Qian, Zhicheng Gong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2016-12-01
Seri Bilgileri:Frontiers in Pharmacology
Konular:
clinical trials
Mitochondrial function
tigecycline
AKT signaling
Anti-cancer effects
Online Erişim:http://journal.frontiersin.org/Journal/10.3389/fphar.2016.00473/full
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller